Korean-owned Samyang Biopharm’s new plant built for EUR 26.2 million has been inaugurated in Gödöllő where synthetic suture materials are manufactured. The company plans to ramp up production gradually, and it will create 55 jobs. South Korean Samyang Group has been present in Hungary since 2010 when Samyang EP Magyarország Kft. started to manufacture plastic […]
Quarterly operating profit growth was 10.1% without FX effects driven by favorable changes in the product portfolio mix and a relatively slower increase of operating expenses, the pharma company Gedeon Richter reports. In addition, no windfall tax was recorded in 2022 Q1. Excluding FX effects Richter’s gross profit increased by 15.3%, driven by a 17.4% […]
Swiss-owned pharma company Novartis expands its Hungarian presence by adding a regional R&D center. Apart from its core research functions, the facility will play a crucial role in coordinating related activities in several countries. Having a tradition of over 250 years, the establishment of Novartis’ Hungarian operation dates back to the early nineties. As part […]
The Hungarian pharmaceutical company Gedeon Richter Plc. presented its results for the year 2022 this Tuesday. The report caused a price drop on the stock market, as it turned out that the always massively profitable company turned loss-making in the last quarter of the year (due to the special tax and the exchange rate change). […]
Gedeon Richter Plc. and Mithra Pharmaceuticals have announced that they signed a license agreement for the commercialisation of Donesta®, a novel product candidate for the treatment of post-menopausal symptoms, according to a statement on the website of the Budapest Stock Exchange. The completion of the agreement follows the signing of the Binding Term Sheet by […]
The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has acquired from shareholders of Consilient Health 100% control of OC Distributors Ltd., an Ireland based company holding the marketing and distribution rights of a number of women’s healthcare products. The transaction value is GBP 32.5 […]
